High-Sensitivity Troponin Protocol Most Successful at Freestanding EDs

Why It Matters

The accelerated protocol dramatically improves throughput and reduces costs for freestanding EDs while maintaining patient safety, signaling a shift in acute cardiac care delivery.

Key Takeaways

• Freestanding EDs discharged 95% using accelerated protocol.
• Hospital EDs discharged ~50% under same protocol.
• Safety outcomes remained comparable across both care settings.
• Accelerated pathway cuts testing and length of stay.
• Freestanding EDs represent 11% of US emergency sites.

Pulse Analysis

High‑sensitivity cardiac troponin assays have reshaped acute coronary syndrome evaluation by delivering reliable results within an hour, a stark contrast to the multi‑hour conventional tests. The Rapid Acute Coronary Syndrome Exclusion using high‑sensitivity I cardiac Troponin (RACE‑IT) study, recently published in Academic Emergency Medicine, examined how this accelerated protocol performs in both traditional hospital emergency departments and the rapidly expanding freestanding ED model. By enrolling over 32,000 chest‑pain patients across the Henry Ford Health System, the trial provides one of the largest real‑world comparisons of rapid rule‑out pathways outside a hospital setting.

Results show a pronounced operational edge for freestanding facilities. Under the accelerated protocol, 95 % of low‑risk patients were safely discharged from freestanding EDs, compared with just 50 % in hospital EDs using the same algorithm. Safety metrics—including 30‑day major adverse cardiac events—remained statistically indistinguishable between the two environments, confirming that speed does not sacrifice patient protection. Moreover, the faster rule‑out reduced overall emergency department length of stay, lowered cardiac testing volume, and minimized unnecessary cardiology consultations.

These findings carry strategic weight as freestanding EDs now account for roughly 11 % of the nation’s 5,200 emergency sites and continue to grow. Demonstrating that high‑sensitivity troponin pathways can be deployed safely in outpatient settings supports broader adoption, potentially easing hospital crowding and lowering Medicare expenditures linked to prolonged observation. Health systems may leverage this evidence to standardize accelerated cardiac protocols across all acute care venues, aligning clinical efficiency with revenue cycle optimization while preserving the quality of care that regulators and patients demand.